Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 14 | 2019 | 37 | 1.960 |
Why?
|
| Polycystic Kidney Diseases | 12 | 2018 | 26 | 1.940 |
Why?
|
| Kidney | 20 | 2016 | 285 | 1.170 |
Why?
|
| Disease Progression | 9 | 2018 | 473 | 0.380 |
Why?
|
| Radioisotope Renography | 3 | 2016 | 29 | 0.360 |
Why?
|
| Rats | 17 | 2019 | 1564 | 0.300 |
Why?
|
| Verapamil | 1 | 2008 | 9 | 0.290 |
Why?
|
| Nephrology | 1 | 2008 | 5 | 0.290 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 40 | 0.290 |
Why?
|
| Cell Proliferation | 2 | 2008 | 804 | 0.280 |
Why?
|
| RNA, Messenger | 8 | 2001 | 656 | 0.270 |
Why?
|
| Animals | 24 | 2019 | 10399 | 0.270 |
Why?
|
| Chemokine CCL2 | 2 | 2003 | 47 | 0.240 |
Why?
|
| Hippurates | 2 | 2015 | 25 | 0.240 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 100 | 0.220 |
Why?
|
| Cyclic AMP | 4 | 2008 | 86 | 0.200 |
Why?
|
| Rats, Inbred Strains | 8 | 2001 | 63 | 0.190 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 215 | 0.190 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 8 | 0.190 |
Why?
|
| Calcium Oxalate | 1 | 2019 | 1 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2019 | 22 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 3 | 2010 | 69 | 0.150 |
Why?
|
| Heterozygote | 6 | 2015 | 65 | 0.150 |
Why?
|
| Europe | 1 | 2018 | 98 | 0.150 |
Why?
|
| Humans | 13 | 2019 | 28121 | 0.140 |
Why?
|
| Epidermal Growth Factor | 2 | 2003 | 23 | 0.140 |
Why?
|
| TRPP Cation Channels | 1 | 2017 | 26 | 0.140 |
Why?
|
| Testosterone | 1 | 1997 | 70 | 0.130 |
Why?
|
| Iodohippuric Acid | 1 | 2016 | 9 | 0.130 |
Why?
|
| Male | 18 | 2019 | 13487 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 1995 | 48 | 0.120 |
Why?
|
| Fluorine Radioisotopes | 1 | 2015 | 27 | 0.120 |
Why?
|
| Female | 17 | 2019 | 15156 | 0.120 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2014 | 8 | 0.120 |
Why?
|
| Glycoproteins | 1 | 1995 | 122 | 0.120 |
Why?
|
| Glycine | 1 | 2014 | 31 | 0.110 |
Why?
|
| Coordination Complexes | 1 | 2014 | 27 | 0.110 |
Why?
|
| Urothelium | 1 | 2014 | 35 | 0.110 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 72 | 0.110 |
Why?
|
| CD13 Antigens | 1 | 2014 | 26 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2016 | 543 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 37 | 0.110 |
Why?
|
| Technetium | 1 | 2014 | 43 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2014 | 97 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 462 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 87 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 1461 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 164 | 0.100 |
Why?
|
| Renal Insufficiency | 2 | 2004 | 20 | 0.090 |
Why?
|
| Body Fluids | 2 | 2008 | 18 | 0.080 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1990 | 2 | 0.080 |
Why?
|
| Kidney Medulla | 1 | 1990 | 2 | 0.080 |
Why?
|
| Sorbitol | 1 | 1990 | 3 | 0.080 |
Why?
|
| Piperacillin | 1 | 2010 | 2 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 1990 | 6 | 0.080 |
Why?
|
| Aldehyde Reductase | 1 | 1990 | 7 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 23 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 95 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 4 | 1997 | 9 | 0.080 |
Why?
|
| Ammonium Chloride | 2 | 2001 | 4 | 0.080 |
Why?
|
| Homozygote | 4 | 1997 | 36 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 113 | 0.070 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2008 | 2 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 6 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 34 | 0.070 |
Why?
|
| Contraindications | 1 | 2008 | 13 | 0.070 |
Why?
|
| Caspases | 1 | 2008 | 42 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 1987 | 15 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2007 | 7 | 0.070 |
Why?
|
| Sirolimus | 1 | 2008 | 76 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2007 | 34 | 0.070 |
Why?
|
| Mice | 9 | 2019 | 4645 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2007 | 43 | 0.070 |
Why?
|
| Calcium | 1 | 2008 | 235 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2003 | 6 | 0.070 |
Why?
|
| Reference Values | 2 | 2001 | 200 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2016 | 136 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 523 | 0.060 |
Why?
|
| Hypertension | 1 | 2008 | 309 | 0.060 |
Why?
|
| Apoptosis | 1 | 2008 | 771 | 0.060 |
Why?
|
| Organ Size | 4 | 2001 | 85 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2007 | 19 | 0.050 |
Why?
|
| Uremia | 4 | 2001 | 5 | 0.050 |
Why?
|
| Osteopontin | 1 | 2001 | 10 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2008 | 2380 | 0.050 |
Why?
|
| Cytokines | 1 | 2003 | 445 | 0.040 |
Why?
|
| Sodium Bicarbonate | 1 | 2001 | 5 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2001 | 172 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2001 | 73 | 0.040 |
Why?
|
| Citric Acid | 1 | 2019 | 4 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 11 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 73 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1998 | 14 | 0.040 |
Why?
|
| Macrophages | 1 | 2001 | 296 | 0.040 |
Why?
|
| Risk Factors | 1 | 2004 | 2084 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 477 | 0.040 |
Why?
|
| Biomarkers | 2 | 2003 | 755 | 0.030 |
Why?
|
| Renal Agents | 1 | 1997 | 2 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 9 | 0.030 |
Why?
|
| Orchiectomy | 1 | 1997 | 12 | 0.030 |
Why?
|
| Rats, Mutant Strains | 2 | 1996 | 16 | 0.030 |
Why?
|
| Genes, myc | 2 | 1996 | 9 | 0.030 |
Why?
|
| Ovariectomy | 1 | 1997 | 53 | 0.030 |
Why?
|
| Potassium | 1 | 1996 | 42 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 1996 | 35 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 509 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1996 | 7 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1996 | 65 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2003 | 247 | 0.030 |
Why?
|
| Clusterin | 1 | 1995 | 5 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1996 | 67 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 12 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 46 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1997 | 190 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 67 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 76 | 0.030 |
Why?
|
| Lovastatin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1995 | 15 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 491 | 0.030 |
Why?
|
| RNA | 1 | 1995 | 111 | 0.030 |
Why?
|
| Acetates | 1 | 2014 | 45 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1998 | 522 | 0.030 |
Why?
|
| Radioisotopes | 1 | 2014 | 10 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 40 | 0.030 |
Why?
|
| Kidney Cortex | 2 | 2003 | 5 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 330 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 457 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2003 | 33 | 0.030 |
Why?
|
| Middle Aged | 4 | 2007 | 7164 | 0.020 |
Why?
|
| Age Factors | 2 | 2000 | 733 | 0.020 |
Why?
|
| Peptides | 1 | 2014 | 289 | 0.020 |
Why?
|
| Gene Expression | 1 | 1993 | 414 | 0.020 |
Why?
|
| Histones | 2 | 1988 | 92 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2003 | 985 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 1990 | 1 | 0.020 |
Why?
|
| Dehydration | 1 | 1990 | 6 | 0.020 |
Why?
|
| Diuretics | 1 | 1990 | 12 | 0.020 |
Why?
|
| Bacteremia | 1 | 2010 | 80 | 0.020 |
Why?
|
| Adult | 3 | 2010 | 7757 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1987 | 21 | 0.020 |
Why?
|
| Fibrosis | 2 | 2001 | 133 | 0.020 |
Why?
|
| Autopsy | 1 | 2007 | 25 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 19 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 67 | 0.020 |
Why?
|
| Regeneration | 1 | 1987 | 77 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2007 | 52 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 1996 | 30 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 454 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1987 | 633 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1998 | 180 | 0.010 |
Why?
|
| Cyst Fluid | 1 | 2003 | 2 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2003 | 45 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2003 | 2 | 0.010 |
Why?
|
| Sex Factors | 2 | 1995 | 465 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2003 | 6 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 78 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 33 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 613 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 123 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 267 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 248 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 510 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 575 | 0.010 |
Why?
|
| Bicarbonates | 1 | 2001 | 3 | 0.010 |
Why?
|
| Chlorides | 1 | 2000 | 13 | 0.010 |
Why?
|
| Ammonia | 1 | 2001 | 18 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 61 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 191 | 0.010 |
Why?
|
| Aging | 2 | 1998 | 976 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 475 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 42 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 49 | 0.010 |
Why?
|
| Epithelium | 1 | 1998 | 39 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 803 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 1997 | 1570 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1998 | 79 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 103 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 58 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 329 | 0.010 |
Why?
|
| Random Allocation | 1 | 1997 | 151 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1593 | 0.010 |
Why?
|
| Papaverine | 1 | 1996 | 1 | 0.010 |
Why?
|
| Inflammation | 1 | 2001 | 626 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 24 | 0.010 |
Why?
|
| Dopamine | 1 | 1996 | 21 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1996 | 31 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1996 | 36 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 58 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1996 | 34 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 88 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 79 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1996 | 44 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 116 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 208 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 605 | 0.010 |
Why?
|
| Nephritis | 1 | 1995 | 10 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 390 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 402 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 5416 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1988 | 3 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 94 | 0.000 |
Why?
|
| Cell Division | 1 | 1988 | 154 | 0.000 |
Why?
|
| Body Weight | 1 | 1988 | 250 | 0.000 |
Why?
|